오메가 3 성분 시장 : 유형별, 유래별, 용도별, 지역별(2025-2033년)

The global omega 3 ingredients market size reached USD 3.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.6 Billion by 2033, exhibiting a growth rate (CAGR) of 8.72% during 2025-2033.

Omega 3 ingredients are naturally occurring polyunsaturated fatty acids (PUFAs) and nutrients that are imperative for optimal human health. They are widely found in fish, flaxseed, and dietary supplements, such as algal, krill refine tuna, and fish oil. Alpha-linoleic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) are some common ingredient types. Omega 3 ingredients help structure the cell walls, provide energy, and maintain the optimum functioning of the heart, blood vessels, lungs, immune system, and endocrine systems. As a result, they find extensive applications in dietary supplements, infant formulas, clinical nutrition, pet food and feed, and functional foods and beverages.

Omega 3 Ingredients Market Trends:

Rising cases of obesity and heart-related issues across the globe are majorly driving the growth of the market. Omega 3 ingredients are widely used for treating chronic diseases, such as severe hypertriglyceridemia. Additionally, the increasing consumer preference towards high-quality supplement products due to hectic lifestyles and busy schedules is favoring the market growth. In line with this, the widespread adoption of dietary supplements comprising omega-3 fatty acids to maintain overall wellness and health is positively influencing the market growth. Apart from this, manufacturers are widely incorporating advanced technologies in the formulation of omega-3 ingredients to remove environmental pollutants, prevent oxidization, and provide high-temperature resistance, which is providing an impetus to the market growth. Moreover, increasing product utilization in cosmetics, sun care, hair care, personal care, and colored products to achieve balanced hydration, regulate the skin's oil production, subdue breakouts, minimize signs of aging, and soothe irritated or dermatitis skin are propelling the market growth. Other factors, including the rising product adoption in pet and animal feed and the implementation of various government entities regarding nutritional claims of omega-3 in food products, are supporting the market growth.

Key Market Segmentation:

Breakup by Type:

• Alpha-linolenic Acid (ALA)
• Docosahexaenoic Acid (DHA)
• Eicosapentaenoic Acid (EPA)

Breakup by Source:

• Marine Source
• Plant Source

Breakup by Application:

• Supplements and Functional Foods
• Pharmaceuticals
• Infant Formula
• Animal Feed

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aker BioMarine ASA, Archer-Daniels-Midland Company, BASF SE, Cargill Incorporated, Cellana Inc., Clover Corporation Limited, Corbion N.V., Croda International Plc, Koninklijke DSM N.V., Omega Protein Corporation (Cooke Inc.), Pelagia AS, Pharma Marine AS and Polaris.

Key Questions Answered in This Report

• 1.What was the size of the global omega 3 ingredients market in 2024?
• 2.What is the expected growth rate of the global omega 3 ingredients market during 2025-2033?
• 3.What are the key factors driving the global omega 3 ingredients market?
• 4.What has been the impact of COVID-19 on the global omega 3 ingredients market?
• 5.What is the breakup of the global omega 3 ingredients market based on the source?
• 6.What is the breakup of the global omega 3 ingredients market based on the application?
• 7.What are the key regions in the global omega 3 ingredients market?
• 8.Who are the key players/companies in the global omega 3 ingredients market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Omega 3 Ingredients Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Alpha-linolenic Acid (ALA)
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Docosahexaenoic Acid (DHA)
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Eicosapentaenoic Acid (EPA)
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Source

• 7.1 Marine Source
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Plant Source
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Application

• 8.1 Supplements and Functional Foods
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Pharmaceuticals
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Infant Formula
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Animal Feed
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Aker BioMarine ASA
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
  • 14.3.2 Archer-Daniels-Midland Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 BASF SE
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 Cargill Incorporated
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Cellana Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
  • 14.3.6 Clover Corporation Limited
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Corbion N.V.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
  • 14.3.8 Croda International Plc
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Koninklijke DSM N.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Omega Protein Corporation (Cooke Inc.)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Pelagia AS
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
  • 14.3.12 Pharma Marine AS
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
  • 14.3.13 Polaris
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio